|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/18 | |
| C07K 16/40 | |||
| A61P 29/00 | |||
| A61P 37/06 |
| (11) | Number of the document | 3095795 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16177656.2 |
| Date of filing the European patent application | 2015-03-06 | |
| (97) | Date of publication of the European application | 2016-11-23 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201461949932 P | 2014-03-07 | US |
| (72) |
ANDRIEN, Bruce, A., Jr., US
SHERIDAN, Douglas L, US
TAMBURINI, Paul P, US
WANG, Yi, US
|
| (73) |
Alexion Pharmaceuticals, Inc.,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (54) | ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS |
| ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS |